Drug Type Proteolysis-targeting chimeras |
Synonyms- |
Target |
Mechanism GRK2 inhibitors(G protein-coupled receptor kinase 2 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | US | 03 Nov 2021 |